Karen Reckamp COSA 2015 ASM

Abstracts this author is presenting:

• Phase 3, randomized trial (CheckMate 017) of nivolumab (Nivo) vs docetaxel in advanced squamous (SQ) cell non-small cell lung cancer (NSCLC) — Posters1